1 2860 133 YOGA-BASED EXERCISE IMPROVES HEALTH-RELATED QUALITY OF LIFE AND MENTAL WELL-BEING IN OLDER PEOPLE: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. OBJECTIVE: HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND MENTAL WELL-BEING ARE ASSOCIATED WITH HEALTHY AGEING. PHYSICAL ACTIVITY POSITIVELY IMPACTS BOTH HRQOL AND MENTAL WELL-BEING. YOGA IS A PHYSICAL ACTIVITY THAT CAN BE MODIFIED TO SUITS THE NEEDS OF OLDER PEOPLE AND IS GROWING IN POPULARITY. WE CONDUCTED A SYSTEMATIC REVIEW WITH META-ANALYSIS TO DETERMINE THE IMPACT OF YOGA-BASED EXERCISE ON HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+. METHODS: SEARCHES WERE CONDUCTED FOR RELEVANT TRIALS IN THE FOLLOWING ELECTRONIC DATABASES; MEDLINE, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, CINAHL, ALLIED AND COMPLEMENTARY MEDICINE DATABASE, PSYCINFO AND THE PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) FROM INCEPTION TO JANUARY 2017. TRIALS THAT EVALUATED THE EFFECT OF PHYSICAL YOGA ON HRQOL AND/OR ON MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS WERE INCLUDED. DATA ON HRQOL AND MENTAL WELL-BEING WERE EXTRACTED. STANDARDISED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING RANDOM EFFECTS MODELS. METHODOLOGICAL QUALITY OF TRIALS WAS ASSESSED USING THE PEDRO SCALE. RESULTS: TWELVE TRIALS OF HIGH METHODOLOGICAL QUALITY (MEAN PEDRO SCORE 6.1), TOTALLING 752 PARTICIPANTS, WERE IDENTIFIED AND PROVIDED DATA FOR THE META-ANALYSIS. YOGA PRODUCED A MEDIUM EFFECT ON HRQOL (HEDGES' G = 0.51, 95% CI 0.25-0.76, 12 TRIALS) AND A SMALL EFFECT ON MENTAL WELL-BEING (HEDGES' G = 0.38, 95% CI 0.15-0.62, 12 TRIALS). CONCLUSION: YOGA INTERVENTIONS RESULTED IN SMALL TO MODERATE IMPROVEMENTS IN BOTH HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS. FURTHER, RESEARCH IS NEEDED TO DETERMINE THE OPTIMAL DOSE OF YOGA TO MAXIMISE HEALTH IMPACT. PROSPERO REGISTRATION NUMBER: (CRD42016052458). 2018 2 2859 92 YOGA-BASED EXERCISE IMPROVES BALANCE AND MOBILITY IN PEOPLE AGED 60 AND OVER: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: ONE-THIRD OF COMMUNITY-DWELLING OLDER ADULTS FALL ANNUALLY. EXERCISE THAT CHALLENGES BALANCE IS PROVEN TO PREVENT FALLS. WE CONDUCTED A SYSTEMATIC REVIEW WITH META-ANALYSIS TO DETERMINE THE IMPACT OF YOGA-BASED EXERCISE ON BALANCE AND PHYSICAL MOBILITY IN PEOPLE AGED 60+ YEARS. METHODS: SEARCHES FOR RELEVANT TRIALS WERE CONDUCTED ON THE FOLLOWING ELECTRONIC DATABASES: MEDLINE, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, CINAHL, ALLIED AND COMPLEMENTARY MEDICINE DATABASE AND THE PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) FROM INCEPTION TO FEBRUARY 2015. TRIALS WERE INCLUDED IF THEY EVALUATED THE EFFECT OF PHYSICAL YOGA (EXCLUDING MEDITATION AND BREATHING EXERCISES ALONE) ON BALANCE IN PEOPLE AGED 60+ YEARS. WE EXTRACTED DATA ON BALANCE AND THE SECONDARY OUTCOME OF PHYSICAL MOBILITY. STANDARDISED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING RANDOM-EFFECTS MODELS. METHODOLOGICAL QUALITY OF TRIALS WAS ASSESSED USING THE 10-POINT PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) SCALE. RESULTS: SIX TRIALS OF RELATIVELY HIGH METHODOLOGICAL QUALITY, TOTALLING 307 PARTICIPANTS, WERE IDENTIFIED AND HAD DATA THAT COULD BE INCLUDED IN A META-ANALYSIS. OVERALL, YOGA INTERVENTIONS HAD A SMALL EFFECT ON BALANCE PERFORMANCE (HEDGES' G = 0.40, 95% CI 0.15-0.65, 6 TRIALS) AND A MEDIUM EFFECT ON PHYSICAL MOBILITY (HEDGES' G = 0.50, 95% CI 0.06-0.95, 3 TRIALS). CONCLUSION: YOGA INTERVENTIONS RESULTED IN SMALL IMPROVEMENTS IN BALANCE AND MEDIUM IMPROVEMENTS IN PHYSICAL MOBILITY IN PEOPLE AGED 60+ YEARS. FURTHER RESEARCH IS REQUIRED TO DETERMINE WHETHER YOGA-RELATED IMPROVEMENTS IN BALANCE AND MOBILITY TRANSLATE TO PREVENTION OF FALLS IN OLDER PEOPLE. PROSPERO REGISTRATION NUMBER CRD42015015872. 2016 3 2591 43 YOGA FOR MENOPAUSAL SYMPTOMS-A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR MENOPAUSAL SYMPTOMS. METHODS: MEDLINE (VIA PUBMED), THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, AND SCOPUS WERE SCREENED THROUGH TO FEBRUARY 21, 2017 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING THE EFFECTS OF YOGA ON MENOPAUSAL SYMPTOMS TO THOSE OF NO TREATMENT OR ACTIVE COMPARATORS. STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. TWO AUTHORS INDEPENDENTLY ASSESSED RISK OF BIAS USING THE COCHRANE RISK OF BIAS TOOL. RESULTS: THIRTEEN RCTS WITH 1306 PARTICIPANTS WERE INCLUDED. COMPARED WITH NO TREATMENT, YOGA REDUCED TOTAL MENOPAUSAL SYMPTOMS (SMD=-1.05; 95% CI -1.57 TO -0.53), PSYCHOLOGICAL (SMD=-0.75; 95% CI -1.17 TO -0.34), SOMATIC (SMD=-0.65; 95% CI -1.05 TO -0.25), VASOMOTOR (SMD=-0.76; 95% CI -1.27 TO -0.25), AND UROGENITAL SYMPTOMS (SMD=-0.53; 95% CI -0.81 TO -0.25). COMPARED WITH EXERCISE CONTROLS, ONLY AN EFFECT ON VASOMOTOR SYMPTOMS WAS FOUND (SMD=-0.45; 95% CI -0.87 TO -0.04). EFFECTS WERE ROBUST AGAINST SELECTION BIAS, BUT NOT AGAINST DETECTION AND ATTRITION BIAS. NO SERIOUS ADVERSE EVENTS WERE REPORTED. CONCLUSION: YOGA SEEMS TO BE EFFECTIVE AND SAFE FOR REDUCING MENOPAUSAL SYMPTOMS. EFFECTS ARE COMPARABLE TO THOSE OF OTHER EXERCISE INTERVENTIONS. 2018 4 2180 36 THE EFFECTS OF YOGA ON PATIENTS WITH PARKINSON'S DISEASE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. METHODS: A META-ANALYSIS WAS CONDUCTED BY SYSTEMATICALLY SEARCHING PUBMED, EMBASE, AND COCHRANE LIBRARY DATABASES TILL AUGUST 2020 FOR STUDIES PUBLISHED IN ENGLISH. THE REFERENCE LISTS OF ELIGIBLE STUDIES WERE ALSO SEARCHED. THE MOTOR SYMPTOMS (UPDRS-PART III), BALANCE FUNCTION (BBS AND BESTEST), FUNCTIONAL MOBILITY (TUG), ANXIETY (HADS AND BAI), DEPRESSION (HADS AND BDI), AND THE QUALITY OF LIFE (PDQ-39 AND PDQ-8) WERE THE PRIMARY EVALUATION INDEXES. RESULTS: TEN STUDIES INCLUDING 359 PARTICIPANTS WERE INCLUDED IN THIS META-ANALYSIS. THE POOLED RESULTS SHOWED SIGNIFICANT DIFFERENCE BETWEEN THE YOGA TRAINING GROUP AND THE CONTROL GROUP. PATIENTS IN THE YOGA TRAINING GROUP HAD BETTER FUNCTIONAL OUTCOMES IN TERMS OF MOTOR STATUS (MD = -5.64; 95% CI, -8.57 TO -2.7), BALANCE FUNCTION (SMD = 0.42; 95% CI, 0.08 TO 0.77), FUNCTIONAL MOBILITY (MD = -1.71; 95% CI, -2.58 TO -0.84), ANXIETY SCALE SCORES (SMD = -0.72; 95% CI, -1.01 TO -0.43), DEPRESSION SCALE SCORES (SMD = -0.92; 95% CI, -1.22 TO -0.62), AND QOL (SMD = -0.54; 95% CI, -0.97 TO -0.11). CONCLUSION: OUR POOLED RESULTS SHOWED THE BENEFITS OF YOGA IN IMPROVING MOTOR FUNCTION, BALANCE, FUNCTIONAL MOBILITY, REDUCING ANXIETY AND DEPRESSION, AND INCREASING QOL IN PD PATIENTS. 2021 5 2634 45 YOGA FOR TREATING LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS. ABSTRACT: YOGA IS FREQUENTLY USED FOR BACK PAIN RELIEF. HOWEVER, THE EVIDENCE WAS JUDGED TO BE OF ONLY LOW TO MODERATE CERTAINTY. TO ASSESS THE EFFICACY AND SAFETY OF YOGA IN PATIENTS WITH LOW BACK PAIN, A META-ANALYSIS WAS PERFORMED. THEREFORE, MEDLINE/PUBMED, SCOPUS, AND THE COCHRANE LIBRARY WERE SEARCHED TO MAY 26, 2020. ONLY RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH PASSIVE CONTROL (USUAL CARE OR WAIT LIST), OR AN ACTIVE COMPARATOR, FOR PATIENTS WITH LOW BACK PAIN AND THAT ASSESSED PAIN INTENSITY OR PAIN-RELATED DISABILITY AS A PRIMARY OUTCOME WERE CONSIDERED TO BE ELIGIBLE. TWO REVIEWERS INDEPENDENTLY EXTRACTED DATA ON STUDY CHARACTERISTICS, OUTCOME MEASURES, AND RESULTS AT SHORT-TERM AND LONG-TERM FOLLOW-UP. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. THIRTY ARTICLES ON 27 INDIVIDUAL STUDIES (2702 PARTICIPANTS IN TOTAL) PROVED ELIGIBLE FOR REVIEW. COMPARED WITH PASSIVE CONTROL, YOGA WAS ASSOCIATED WITH SHORT-TERM IMPROVEMENTS IN PAIN INTENSITY (15 RCTS; MEAN DIFFERENCE [MD] = -0.74 POINTS ON A NUMERIC RATING SCALE; 95% CONFIDENCE INTERVAL [CI] = -1.04 TO -0.44; STANDARDIZED MEAN DIFFERENCE [SMD] = -0.37 95% CI = -0.52 TO -0.22), PAIN-RELATED DISABILITY (15 RCTS; MD = -2.28; 95% CI = -3.30 TO -1.26; SMD = -0.38 95% CI = -0.55 TO -0.21), MENTAL HEALTH (7 RCTS; MD = 1.70; 95% CI = 0.20-3.20; SMD = 0.17 95% CI = 0.02-0.32), AND PHYSICAL FUNCTIONING (9 RCTS; MD = 2.80; 95% CI = 1.00-4.70; SMD = 0.28 95% CI = 0.10-0.47). EXCEPT FOR MENTAL HEALTH, ALL EFFECTS WERE SUSTAINED LONG-TERM. COMPARED WITH AN ACTIVE COMPARATOR, YOGA WAS NOT ASSOCIATED WITH ANY SIGNIFICANT DIFFERENCES IN SHORT-TERM OR LONG-TERM OUTCOMES. 2022 6 2544 51 YOGA FOR ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: ALTHOUGH YOGA IS FREQUENTLY USED BY PATIENTS WITH ASTHMA, ITS EFFICACY IN ALLEVIATING ASTHMA REMAINS UNCLEAR. OBJECTIVE: TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE AVAILABLE DATA ON EFFICACY AND SAFETY OF YOGA IN ALLEVIATING ASTHMA. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, PSYCINFO, CAM-QUEST, CAMBASE, AND INDMED WERE SEARCHED THROUGH JANUARY 2014. RANDOMIZED CONTROLLED TRIALS OF YOGA FOR PATIENTS WITH ASTHMA WERE INCLUDED IF THEY ASSESSED ASTHMA CONTROL, SYMPTOMS, QUALITY OF LIFE, AND/OR PULMONARY FUNCTION. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMDS) OR RISK RATIOS (RRS) AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: FOURTEEN RANDOMIZED CONTROLLED TRIALS WITH 824 PATIENTS WERE INCLUDED. EVIDENCE FOR EFFECTS OF YOGA COMPARED WITH USUAL CARE WAS FOUND FOR ASTHMA CONTROL (RR, 10.64; 95% CI, 1.98 TO 57.19; P = .006), ASTHMA SYMPTOMS (SMD, -0.37; 95% CI, -0.55 TO -0.19; P < .001), QUALITY OF LIFE (SMD, 0.86; 95% CI, 0.39 TO 1.33; P < .001), PEAK EXPIRATORY FLOW RATE (SMD, 0.49; 95% CI, 0.32 TO 0.67; P < .001), AND RATIO OF FORCED EXPIRATORY VOLUME IN 1 SECOND TO FORCED VITAL CAPACITY (SMD, 0.50; 95% CI, 0.24 TO 0.75; P < .001); EVIDENCE FOR EFFECTS OF YOGA COMPARED WITH PSYCHOLOGICAL INTERVENTIONS WAS FOUND FOR QUALITY OF LIFE (SMD, 0.61; 95% CI, 0.22 TO 0.99; P = .002) AND PEAK EXPIRATORY FLOW RATE (SMD, 2.87; 95% CI, 0.14 TO 5.60; P = .04). NO EVIDENCE FOR EFFECTS OF YOGA COMPARED WITH SHAM YOGA OR BREATHING EXERCISES WAS REVEALED. NO EFFECT WAS ROBUST AGAINST ALL POTENTIAL SOURCES OF BIAS. YOGA WAS NOT ASSOCIATED WITH SERIOUS ADVERSE EVENTS. CONCLUSION: YOGA CANNOT BE CONSIDERED A ROUTINE INTERVENTION FOR ASTHMATIC PATIENTS AT THIS POINT. IT CAN BE CONSIDERED AN ANCILLARY INTERVENTION OR AN ALTERNATIVE TO BREATHING EXERCISES FOR ASTHMA PATIENTS INTERESTED IN COMPLEMENTARY INTERVENTIONS. 2014 7 1061 53 EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: YOGA RECEIVE MORE ATTENTION FROM BREAST CANCER PATIENTS, HOWEVER ITS FEASIBILITY AND EFFICACY DURING CHEMOTHERAPY REMAINS CONFLICTING. WE PERFORMED THIS SYSTEMATIC REVIEW TO ASSESS THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY. METHODS: A SYSTEMATIC SEARCH WAS CONDUCTED TO RETRIEVE RANDOMIZED CONTROLLED TRIALS (RCTS) WHICH INVESTIGATED THE COMPARATIVE EFFICACY OF YOGA VERSUS COMPARATORS SUCH AS USUAL CARE AMONG BREAST CANCER PATIENTS FOR HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN PUBMED, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CNETRAL), NURSING AND ALLIED HEALTH LITERATURE (CINAHL), CHINESE BIOMEDICAL LITERATURE (CBM) DATABASE, CHINA SCIENCE AND TECHNOLOGY JOURNAL (CSTJ) DATABASE, CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE (CNKI), AND WANGFANG DATABASE FROM INCEPTION TO DECEMBER 2018. THE LATEST SEARCH WAS UPDATED ON SEPTEMBER 2020. ALL ANALYSES WERE COMPLETED USING REVMAN VERSION 5.3. RESULTS: SEVEN TRIALS INVOLVING 693 BREAST CANCER PATIENTS MET INCLUSION CRITERIA. META-ANALYSIS INDICATED A SHORT-TERM IMPROVEMENT IN FATIGUE [STANDARD MEAN DIFFERENCE (SMD), -0.62; 95% CONFIDENCE INTERVAL (CI), -1.17 TO -0.07], SLEEP DISTURBANCE (SMD, -0.34; 95% CI, -0.55 TO -0.12), DEPRESSION (SMD, -0.50; 95% CI, -0.70 TO -0.31) ANXIETY (SMD, -0.50; 95% CI, -0.70 TO -0.31), AND HEALTH-RELATED QUALITY OF LIFE (QOL) (SMD, 0.72; 95% CI, -0.12 TO 1.56) IN THE YOGA GROUP; HOWEVER BENEFICIAL MEDIUM- AND LONG-TERM EFFECTS IN FATIGUE, SLEEP DISTURBANCE WERE NOT IDENTIFIED. MOREOVER, QUALITATIVE ANALYSES SUGGESTED THAT YOGA WAS NOT ASSOCIATED WITH DECREASED ADVERSE EVENTS (AES) COMPARED WITH CONTROL GROUPS. CONCLUSIONS: YOGA MAY BENEFIT TO REDUCE FATIGUE, DEPRESSION AND ANXIETY, IMPROVE SLEEP DISTURBANCE, AND IMPROVE QOL IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY IN THE SHORT-TERM; HOWEVER, MEDIUM- AND LONG-TERM EFFECTS SHOULD BE FURTHER ESTABLISHED OWING TO LIMITATIONS. 2021 8 2546 53 YOGA FOR BREAST CANCER PATIENTS AND SURVIVORS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: MANY BREAST CANCER PATIENTS AND SURVIVORS USE YOGA TO COPE WITH THEIR DISEASE. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EVIDENCE FOR EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE AND PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS AND SURVIVORS. METHODS: MEDLINE, PSYCINFO, EMBASE, CAMBASE, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH FEBRUARY 2012. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO CONTROLS WERE ANALYZED WHEN THEY ASSESSED HEALTH-RELATED QUALITY OF LIFE OR PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS OR SURVIVORS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULTS: TWELVE RCTS WITH A TOTAL OF 742 PARTICIPANTS WERE INCLUDED. SEVEN RCTS COMPARED YOGA TO NO TREATMENT; 3 RCTS COMPARED YOGA TO SUPPORTIVE THERAPY; 1 RCT COMPARED YOGA TO HEALTH EDUCATION; AND 1 RCT COMPARED A COMBINATION OF PHYSIOTHERAPY AND YOGA TO PHYSIOTHERAPY ALONE. EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON GLOBAL HEALTH-RELATED QUALITY OF LIFE (SMD = 0.62 [95% CI: 0.04 TO 1.21]; P = 0.04), FUNCTIONAL (SMD = 0.30 [95% CI: 0.03 TO 0.57), SOCIAL (SMD = 0.29 [95% CI: 0.08 TO 0.50]; P < 0.01), AND SPIRITUAL WELL-BEING (SMD = 0.41 [95% CI: 0.08; 0.74]; P = 0.01). THESE EFFECTS WERE, HOWEVER, ONLY PRESENT IN STUDIES WITH UNCLEAR OR HIGH RISK OF SELECTION BIAS. SHORT-TERM EFFECTS ON PSYCHOLOGICAL HEALTH ALSO WERE FOUND: ANXIETY (SMD = -1.51 [95% CI: -2.47; -0.55]; P < 0.01), DEPRESSION (SMD = -1.59 [95% CI: -2.68 TO -0.51]; P < 0.01), PERCEIVED STRESS (SMD = -1.14 [95% CI:-2.16; -0.12]; P = 0.03), AND PSYCHOLOGICAL DISTRESS (SMD = -0.86 [95% CI:-1.50; -0.22]; P < 0.01). SUBGROUP ANALYSES REVEALED EVIDENCE OF EFFICACY ONLY FOR YOGA DURING ACTIVE CANCER TREATMENT BUT NOT AFTER COMPLETION OF ACTIVE TREATMENT. CONCLUSIONS: THIS SYSTEMATIC REVIEW FOUND EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA IN IMPROVING PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS. THE SHORT-TERM EFFECTS ON HEALTH-RELATED QUALITY OF LIFE COULD NOT BE CLEARLY DISTINGUISHED FROM BIAS. YOGA CAN BE RECOMMENDED AS AN INTERVENTION TO IMPROVE PSYCHOLOGICAL HEALTH DURING BREAST CANCER TREATMENT. 2012 9 1038 53 EFFECTS OF YOGA IN PATIENTS WITH CHRONIC HEART FAILURE: A META-ANALYSIS. THE USE OF YOGA AS AN EFFECTIVE CARDIAC REHABILITATION IN PATIENTS WITH CHRONIC HEART FAILURE (CHF) REMAINS CONTROVERSIAL. WE PERFORMED A META-ANALYSIS TO EXAMINE THE EFFECTS OF YOGA ON EXERCISE CAPACITY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH CHF. METHODS: WE SEARCHED MEDLINE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, EXCERPTA MEDICA DATABASE, LILACS, PHYSIOTHERAPY EVIDENCE DATABASE, THE SCIENTIFIC ELECTRONIC LIBRARY ONLINE, AND CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH (FROM THE EARLIEST DATE AVAILABLE TO DECEMBER 2013) FOR RANDOMIZED CONTROLLED TRIALS (RCTS) EXAMINING THE EFFECTS OF YOGA VERSUS EXERCISE AND/OR OF YOGA VERSUS CONTROL ON EXERCISE CAPACITY (PEAKVO2) AND QUALITY-OF-LIFE (HRQOL) IN CHF. TWO REVIEWERS SELECTED STUDIES INDEPENDENTLY. WEIGHTED MEAN DIFFERENCES (WMDS) AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED, AND HETEROGENEITY WAS ASSESSED USING THE I2 TEST. TWO STUDIES MET THE SELECTION CRITERIA (TOTAL: 30 YOGA AND 29 CONTROL PATIENTS). THE RESULTS SUGGESTED THAT YOGA COMPARED WITH CONTROL HAD A POSITIVE IMPACT ON PEAK VO2 AND HRQOL. PEAK VO2, WMD (3.87 95% CI: 1.95 TO 5.80), AND GLOBAL HRQOL STANDARDIZED MEAN DIFFERENCES (-12.46 95% CI: -22.49 TO -2.43) IMPROVED IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. YOGA ENHANCES PEAK VO2 AND HRQOL IN PATIENTS WITH CHF AND COULD BE CONSIDERED FOR INCLUSION IN CARDIAC REHABILITATION PROGRAMS. LARGER RCTS ARE REQUIRED TO FURTHER INVESTIGATE THE EFFECTS OF YOGA IN PATIENTS WITH CHF. 2014 10 2614 45 YOGA FOR SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTS OF YOGA ON SYMPTOMS OF SCHIZOPHRENIA, QUALITY OF LIFE, FUNCTION, AND HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, PSYCINFO, AND INDMED WERE SCREENED THROUGH AUGUST 2012. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO USUAL CARE OR NON-PHARMACOLOGICAL INTERVENTIONS WERE ANALYZED WHEN THEY ASSESSED SYMPTOMS OR QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA. COGNITIVE FUNCTION, SOCIAL FUNCTION, HOSPITALIZATION, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED USING THE RISK OF BIAS TOOL RECOMMENDED BY THE COCHRANE BACK REVIEW GROUP. STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULTS: FIVE RCTS WITH A TOTAL OF 337 PATIENTS WERE INCLUDED; 2 RCTS HAD LOW RISK OF BIAS. TWO RCTS COMPARED YOGA TO USUAL CARE; 1 RCT COMPARED YOGA TO EXERCISE; AND 2 3-ARM RCTS COMPARED YOGA TO USUAL CARE AND EXERCISE. NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS OF YOGA COMPARED TO USUAL CARE ON POSITIVE SYMPTOMS (SMD = -0.58; 95% CI -1.52 TO 0.37; P = 0.23), OR NEGATIVE SYMPTOMS (SMD = -0.59; 95% CI -1.87 TO 0.69; P = 0.36). MODERATE EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON QUALITY OF LIFE COMPARED TO USUAL CARE (SMD = 2.28; 95% CI 0.42 TO 4.14; P = 0.02). THESE EFFECTS WERE ONLY PRESENT IN STUDIES WITH HIGH RISK OF BIAS. NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON SOCIAL FUNCTION (SMD = 1.20; 95% CI -0.78 TO 3.18; P = 0.23). COMPARING YOGA TO EXERCISE, NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON POSITIVE SYMPTOMS (SMD = -0.35; 95% CI -0.75 TO 0.05; P = 0.09), NEGATIVE SYMPTOMS (SMD = -0.28; 95% CI -1.42 TO 0.86; P = 0.63), QUALITY OF LIFE (SMD = 0.17; 95% CI -0.27 TO 0.61; P = 0.45), OR SOCIAL FUNCTION (SMD = 0.20; 95% CI -0.27 TO 0.67; P = 0.41). ONLY 1 RCT REPORTED ADVERSE EVENTS. CONCLUSIONS: THIS SYSTEMATIC REVIEW FOUND ONLY MODERATE EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA ON QUALITY OF LIFE. AS THESE EFFECTS WERE NOT CLEARLY DISTINGUISHABLE FROM BIAS AND SAFETY OF THE INTERVENTION WAS UNCLEAR, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR SCHIZOPHRENIA PATIENTS. 2013 11 222 48 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR LOW BACK PAIN. OBJECTIVES: TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR LOW BACK PAIN. METHODS: MEDLINE, THE COCHRANE LIBRARY, EMBASE, CAMBASE, AND PSYCINFO, WERE SCREENED THROUGH JANUARY 2012. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA TO CONTROL CONDITIONS IN PATIENTS WITH LOW BACK PAIN WERE INCLUDED. TWO AUTHORS INDEPENDENTLY ASSESSED RISK OF BIAS USING THE RISK OF BIAS TOOL RECOMMENDED BY THE COCHRANE BACK REVIEW GROUP. MAIN OUTCOME MEASURES WERE PAIN, BACK-SPECIFIC DISABILITY, GENERIC DISABILITY, HEALTH-RELATED QUALITY OF LIFE, AND GLOBAL IMPROVEMENT. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULTS: TEN RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 967 CHRONIC LOW BACK PAIN PATIENTS WERE INCLUDED. EIGHT STUDIES HAD LOW RISK OF BIAS. THERE WAS STRONG EVIDENCE FOR SHORT-TERM EFFECTS ON PAIN (SMD=-0.48; 95% CI, -0.65 TO -0.31; P<0.01), BACK-SPECIFIC DISABILITY (SMD=-0.59; 95% CI, -0.87 TO -0.30; P<0.01), AND GLOBAL IMPROVEMENT (RISK RATIO=3.27; 95% CI, 1.89-5.66; P<0.01). THERE WAS STRONG EVIDENCE FOR A LONG-TERM EFFECT ON PAIN (SMD=-0.33; 95% CI, -0.59 TO -0.07; P=0.01) AND MODERATE EVIDENCE FOR A LONG-TERM EFFECT ON BACK-SPECIFIC DISABILITY (SMD=-0.35; 95% CI, -0.55 TO -0.15; P<0.01). THERE WAS NO EVIDENCE FOR EITHER SHORT-TERM OR LONG-TERM EFFECTS ON HEALTH-RELATED QUALITY OF LIFE. YOGA WAS NOT ASSOCIATED WITH SERIOUS ADVERSE EVENTS. DISCUSSION: THIS SYSTEMATIC REVIEW FOUND STRONG EVIDENCE FOR SHORT-TERM EFFECTIVENESS AND MODERATE EVIDENCE FOR LONG-TERM EFFECTIVENESS OF YOGA FOR CHRONIC LOW BACK PAIN IN THE MOST IMPORTANT PATIENT-CENTERED OUTCOMES. YOGA CAN BE RECOMMENDED AS AN ADDITIONAL THERAPY TO CHRONIC LOW BACK PAIN PATIENTS. 2013 12 2128 47 THE EFFECTIVENESS OF YOGA IN MODIFYING RISK FACTORS FOR CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: YOGA, A POPULAR MIND-BODY PRACTICE, MAY PRODUCE CHANGES IN CARDIOVASCULAR DISEASE (CVD) AND METABOLIC SYNDROME RISK FACTORS. DESIGN: THIS WAS A SYSTEMATIC REVIEW AND RANDOM-EFFECTS META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS). METHODS: ELECTRONIC SEARCHES OF MEDLINE, EMBASE, CINAHL, PSYCINFO, AND THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS WERE PERFORMED FOR SYSTEMATIC REVIEWS AND RCTS THROUGH DECEMBER 2013. STUDIES WERE INCLUDED IF THEY WERE ENGLISH, PEER-REVIEWED, FOCUSED ON ASANA-BASED YOGA IN ADULTS, AND REPORTED RELEVANT OUTCOMES. TWO REVIEWERS INDEPENDENTLY SELECTED ARTICLES AND ASSESSED QUALITY USING COCHRANE'S RISK OF BIAS TOOL. RESULTS: OUT OF 1404 RECORDS, 37 RCTS WERE INCLUDED IN THE SYSTEMATIC REVIEW AND 32 IN THE META-ANALYSIS. COMPARED TO NON-EXERCISE CONTROLS, YOGA SHOWED SIGNIFICANT IMPROVEMENT FOR BODY MASS INDEX (-0.77 KG/M(2) (95% CONFIDENCE INTERVAL -1.09 TO -0.44)), SYSTOLIC BLOOD PRESSURE (-5.21 MMHG (-8.01 TO -2.42)), LOW-DENSITY LIPOPROTEIN CHOLESTEROL (-12.14 MG/DL (-21.80 TO -2.48)), AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (3.20 MG/DL (1.86 TO 4.54)). SIGNIFICANT CHANGES WERE SEEN IN BODY WEIGHT (-2.32 KG (-4.33 TO -0.37)), DIASTOLIC BLOOD PRESSURE (-4.98 MMHG (-7.17 TO -2.80)), TOTAL CHOLESTEROL (-18.48 MG/DL (-29.16 TO -7.80)), TRIGLYCERIDES (-25.89 MG/DL (-36.19 TO -15.60), AND HEART RATE (-5.27 BEATS/MIN (-9.55 TO -1.00)), BUT NOT FASTING BLOOD GLUCOSE (-5.91 MG/DL (-16.32 TO 4.50)) NOR GLYCOSYLATED HEMOGLOBIN (-0.06% HB (-0.24 TO 0.11)). NO SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN YOGA AND EXERCISE. ONE STUDY FOUND AN IMPACT ON SMOKING ABSTINENCE. CONCLUSIONS: THERE IS PROMISING EVIDENCE OF YOGA ON IMPROVING CARDIO-METABOLIC HEALTH. FINDINGS ARE LIMITED BY SMALL TRIAL SAMPLE SIZES, HETEROGENEITY, AND MODERATE QUALITY OF RCTS. 2016 13 1054 46 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS OF YOGA IN RELIEVING CHRONIC NECK PAIN. METHODS: PUBMED/MEDLINE, THE COCHRANE LIBRARY, SCOPUS, AND INDMED WERE SCREENED THROUGH JANUARY 2017 FOR RANDOMIZED CONTROLLED TRIALS ASSESSING NECK PAIN INTENSITY AND/OR NECK PAIN-RELATED DISABILITY IN CHRONIC NECK PAIN PATIENTS. SECONDARY OUTCOME MEASURES INCLUDED QUALITY OF LIFE, MOOD, AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: THREE STUDIES ON 188 PATIENTS WITH CHRONIC NON-SPECIFIC NECK PAIN COMPARING YOGA TO USUAL CARE WERE INCLUDED. TWO STUDIES HAD OVERALL LOW RISK OF BIAS; AND ONE HAD HIGH OR UNCLEAR RISK OF BIAS FOR SEVERAL DOMAINS. EVIDENCE FOR SHORT-TERM EFFECTS WAS FOUND FOR NECK PAIN INTENSITY (STANDARDIZED MEAN DIFFERENCE (SMD) = -1.28; 95% CONFIDENCE INTERVAL (CI) = -1.18, -0.75; P < 0.001), NECK PAIN-RELATED DISABILITY (SMD = -0.97; 95% CI = -1.44, -0.50; P < 0.001), QUALITY OF LIFE (SMD = 0.57; 95% CI = 0.17, 0.197; P = 0.005), AND MOOD (SMD = -1.02; 95% CI = -1.38, -0.65; P < 0.001). EFFECTS WERE ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS AND DID NOT DIFFER BETWEEN DIFFERENT INTERVENTION SUBGROUPS. IN THE TWO STUDIES THAT INCLUDED SAFETY DATA, NO SERIOUS ADVERSE EVENTS OCCURRED. CONCLUSION: YOGA HAS SHORT-TERM EFFECTS ON CHRONIC NECK PAIN, ITS RELATED DISABILITY, QUALITY OF LIFE, AND MOOD SUGGESTING THAT YOGA MIGHT BE A GOOD TREATMENT OPTION. 2017 14 2846 58 YOGA, HEALTH-RELATED QUALITY OF LIFE AND MENTAL WELL-BEING: A RE-ANALYSIS OF A META-ANALYSIS USING THE QUALITY EFFECTS MODEL. BACKGROUND: PROVIDE ROBUST AND PRACTICALLY RELEVANT INFORMATION REGARDING THE ASSOCIATION BETWEEN YOGA, HEALTH-RELATED QUALITY-OF-LIFE (HRQOL), AND MENTAL WELL-BEING (MWB) IN OLDER ADULTS. METHODS: DATA WERE DERIVED FROM A RECENT META-ANALYSIS OF 12 RANDOMIZED CONTROLLED YOGA TRIALS REPRESENTING 752 ADULTS >/=60 YEARS OF AGE. STANDARDIZED MEAN DIFFERENCE EFFECT SIZES (ESS) WERE POOLED USING THE RECENTLY DEVELOPED QUALITY EFFECTS MODEL AND 95% COMPATIBILITY INTERVALS (CI). SMALL-STUDY EFFECTS WERE EXAMINED USING THE DOI PLOT AND LUIS FURUYA-KANAMORI (LFK) INDEX. SENSITIVITY AND CUMULATIVE META-ANALYSES WERE CONDUCTED AS WELL AS PERCENTILE IMPROVEMENT, NUMBER NEEDED TO TREAT (NNT), AND NUMBER TO BENEFIT. THE GRADING OF RECOMMENDATIONS ASSESSMENT, DEVELOPMENT, AND EVALUATION (GRADE) INSTRUMENT WAS USED TO ASSESS THE STRENGTH OF THE EVIDENCE. RESULTS: YOGA WAS ASSOCIATED WITH IMPROVEMENTS IN BOTH HRQOL (ES = 0.51, 95% CI, 0.25-0.77, I2 = 63.1%) AND MWB (ES = 0.39, 95% CI, 0.15-0.63, I2 =56.2%). PERCENTILE IMPROVEMENTS WERE 19.5 FOR HRQOL AND 15.3 FOR MWB WHEREAS THE NNT WAS 4 FOR HRQOL AND 5 FOR MWB. AN ESTIMATED 378,222 AND 302,578 U.S. YOGA-PRACTICING ADULTS >/=65 YEARS OF AGE COULD POTENTIALLY IMPROVE THEIR HRQOL AND MWB, RESPECTIVELY. MAJOR ASYMMETRY SUGGESTIVE OF SMALL-STUDY EFFECTS WAS OBSERVED FOR MWB BUT NOT HRQOL. FURTHER EXAMINATION FOR ASYMMETRY REVEALED THAT GREATER IMPROVEMENTS IN MWB WERE ASSOCIATED WITH MORE (151 VS. 68) MINUTES OF YOGA PER WEEK (P = .007). OVERALL STRENGTH OF EVIDENCE WAS CONSIDERED "HIGH" FOR HRQOL AND "MODERATE" FOR MWB. CONCLUSIONS: YOGA IS ASSOCIATED WITH IMPROVEMENTS IN HRQOL AND MWB AMONG OLDER ADULTS, WITH APPROXIMATELY 150 MINUTES OR MORE PER WEEK POSSIBLY OPTIMAL. 2020 15 2599 42 YOGA FOR OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. PURPOSE OF REVIEW: THIS STUDY AIMS TO SYSTEMATICALLY REVIEW AND SUMMARISE THE EFFICACY AND SAFETY OF YOGA FOR OSTEOARTHRITIS. MEDLINE (THROUGH PUBMED), SCOPUS, AND THE COCHRANE LIBRARY WERE SEARCHED THROUGH APRIL 2018 FOR RANDOMISED CONTROLLED TRIALS OF YOGA FOR OSTEOARTHRITIS. PRIMARY OUTCOMES WERE PAIN INTENSITY, FUNCTION, AND QUALITY OF LIFE; SECONDARY OUTCOMES WERE MENTAL HEALTH AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL AND QUALITY OF EVIDENCE THROUGH GRADE. RECENT FINDINGS: NINE TRIALS INCLUDING 640 INDIVIDUALS WITH MAINLY LOWER EXTREMITY OSTEOARTHRITIS AGED 50-80 YEARS WERE IDENTIFIED, WITH 80.3% FEMALE PARTICIPANTS (MEDIAN). META-ANALYSES REVEALED VERY LOW-QUALITY EVIDENCE FOR THE EFFECTS OF YOGA ON PAIN (VS. EXERCISE: STANDARDISED MEAN DIFFERENCE (SMD) = - 1.07; 95%CI - 1.92, - 0.21; P = 0.01; VS. NON-EXERCISE: SMD = - 0.75; 95%CI - 1.18, - 0.31; P < 0.001), PHYSICAL FUNCTION (VS. EXERCISE: SMD = 0.80; 95%CI 0.36; 1.24; P < 0.001; VS. NON-EXERCISE: SMD = 0.60; 95%CI 0.30, 0.98; P < 0.001), AND STIFFNESS (VS. EXERCISE: SMD = - 0.92; 95%CI - 1.69, - 0.14; P = 0.008; VS. NON-EXERCISE: SMD = - 0.76; 95%CI - 1.26, - 0.26; P = 0.003) IN INDIVIDUALS WITH KNEE OSTEOARTHRITIS. EFFECTS WERE NOT ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS. NO EFFECTS WERE FOUND FOR QUALITY OF LIFE, AND DEPRESSION, OR FOR HAND OSTEOARTHRITIS. SAFETY WAS RARELY REPORTED. THE FINDINGS OF THIS META-ANALYSIS INDICATE THAT YOGA MAY BE EFFECTIVE FOR IMPROVING PAIN, FUNCTION, AND STIFFNESS IN INDIVIDUALS WITH OSTEOARTHRITIS OF THE KNEE, COMPARED TO EXERCISE AND NON-EXERCISE CONTROL GROUPS. DUE TO THE LOW METHODOLOGICAL QUALITY AND POTENTIAL RISK OF BIAS, ONLY A WEAK RECOMMENDATION CAN BE MADE AT THIS TIME FOR THE USE OF YOGA IN ADULTS WITH OSTEOARTHRITIS OF THE KNEE. 2019 16 2124 44 THE EFFECTIVENESS OF PRENATAL YOGA ON DELIVERY OUTCOMES: A META-ANALYSIS. BACKGROUND: THE EFFICACY OF YOGA ON DELIVERY OUTCOMES REMAINING CONTROVERSY. OBJECTIVES: TO EVALUATE THE EFFECTS OF PRENATAL YOGA ON DELIVERY OUTCOMES. METHODS: THE COCHRANE LIBRARY, PUBMED, EMBASE, WEB OF SCIENCE, CINAHL AND ELSEVIER DATABASES WERE SEARCHED FROM INCEPTION TO JANUARY 22, 2020, AND RANDOMIZED, QUASI-RANDOMIZED AND NON-RANDOMIZED CONTROLLED TRIALS EVALUATING THE EFFECT OF YOGA ON THE DELIVERY OUTCOMES IN PREGNANT WOMEN WERE INCLUDED. THE METHODOLOGICAL QUALITY WAS ASSESSED BY THE COCHRANE COLLABORATION'S TOOL. META-ANALYSIS WAS PERFORMED USING REVMAN 5.3. RESULTS: THIS META-ANALYSIS IDENTIFIED THAT YOGA IMPROVED VAGINAL DELIVERY, DECREASED PREMATURE DELIVERY AND BIRTH WEIGHT OF NEWBORNS, SHORTEN THE LABOR DURATION. CONCLUSION: PRENATAL YOGA IS AN EFFECTIVE COMPLEMENTARY MEDICINE TO IMPROVE DELIVERY OUTCOMES AND NOT TO INCREASE THE RISK OF FETUS, WHICH IS WORTH RECOMMENDING TO PREGNANT WOMEN. BUT STUDIES INVOLVED IN THIS META-ANALYSIS WERE NOT ALL OF HIGH QUALITY. THE REGISTRATION NUMBER IN PROSPERO IS CRD42019132490. 2020 17 2066 50 THE CHARACTERISTICS AND EFFECTIVENESS OF PREGNANCY YOGA INTERVENTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: YOGA IS A POPULAR MIND-BODY MEDICINE FREQUENTLY RECOMMENDED TO PREGNANT WOMEN. GAPS REMAIN IN OUR UNDERSTANDING OF THE CORE COMPONENTS OF EFFECTIVE PREGNANCY YOGA PROGRAMMES. THIS SYSTEMATIC REVIEW AND META-ANALYSIS EXAMINED THE CHARACTERISTICS AND EFFECTIVENESS OF PREGNANCY YOGA INTERVENTIONS, INCORPORATING THE FITT (FREQUENCY, INTENSITY, TIME/DURATION AND TYPE) PRINCIPLE OF EXERCISE PRESCRIPTION. METHODS: NINE ELECTRONIC DATABASES WERE SEARCHED: MEDLINE, PSYCINFO, EMBASE, CINAHL, WHOLIS, AMED, SCIELO, ASSIA AND WEB OF SCIENCE. RANDOMISED CONTROL TRIALS AND QUASI-EXPERIMENTAL STUDIES EXAMINING PREGNANCY YOGA INTERVENTIONS WERE ELIGIBLE. COVIDENCE WAS USED TO SCREEN TITLES, ABSTRACTS, AND FULL-TEXT ARTICLES. OUTCOMES OF INTEREST WERE STRESS, ANXIETY, DEPRESSION, QUALITY OF LIFE, LABOUR DURATION, PAIN MANAGEMENT IN LABOUR AND MODE OF BIRTH. THE COCHRANE COLLABORATION'S RISK OF BIAS ASSESSMENT TOOL WAS USED TO ASSESS METHODOLOGICAL QUALITY OF STUDIES AND GRADE CRITERIA (GRADEPRO) EVALUATED QUALITY OF THE EVIDENCE. META-ANALYSIS WAS PERFORMED USING REVMAN 5.3. RESULTS: OF 862 CITATIONS RETRIEVED, 31 STUDIES MET INCLUSION CRITERIA. TWENTY-NINE STUDIES WITH 2217 PREGNANT WOMEN WERE INCLUDED FOR META-ANALYSIS. PREGNANCY YOGA INTERVENTIONS REDUCED ANXIETY (SMD: -0.91; 95% CI: - 1.49 TO - 0.33; P = 0.002), DEPRESSION (SMD: -0.47; 95% CI: - 0.9 TO - 0.04, P = 0.03) AND PERCEIVED STRESS (SMD: -1.03; 95% CI: - 1.55 TO - 0.52; P < 0.001). YOGA INTERVENTIONS ALSO REDUCED DURATION OF LABOUR (MD = - 117.75; 95% CI - 153.80 TO - 81.71, P < 0.001) AND, INCREASED ODDS OF NORMAL VAGINAL BIRTH (OR 2.58; 95% CI 1.46-4.56, P < 0.001) AND TOLERANCE FOR PAIN. THE QUALITY OF EVIDENCE (GRADE CRITERIA) WAS LOW TO VERY LOW FOR ALL OUTCOMES. TWELVE OR MORE YOGA SESSIONS DELIVERED WEEKLY/BI-WEEKLY HAD A STATISTICALLY SIGNIFICANT IMPACT ON MODE OF BIRTH, WHILE 12 OR MORE YOGA SESSIONS OF LONG DURATION (> 60 MIN) HAD A STATISTICALLY SIGNIFICANT IMPACT ON PERCEIVED STRESS. CONCLUSION: THE EVIDENCE HIGHLIGHTS POSITIVE EFFECTS OF PREGNANCY YOGA ON ANXIETY, DEPRESSION, PERCEIVED STRESS, MODE OF BIRTH AND DURATION OF LABOUR. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42019119916. REGISTERED ON 11TH JANUARY 2019. 2022 18 1033 37 EFFECTS OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS. AIMS/INTRODUCTION: A META-ANALYSIS WAS CARRIED OUT TO EVALUATE THE EFFICACY OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: THE PUBMED, EMBASE AND COCHRANE DATABASES WERE SEARCHED TO OBTAIN ELIGIBLE RANDOMIZED CONTROLLED TRIALS. THE PRIMARY OUTCOME WAS FASTING BLOOD GLUCOSE, AND THE SECONDARY OUTCOMES INCLUDED GLYCOSYLATED HEMOGLOBIN A1C, TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDE AND POSTPRANDIAL BLOOD GLUCOSE. WEIGHTED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. THE I(2) STATISTIC REPRESENTED HETEROGENEITY. RESULTS: A TOTAL OF 12 RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 864 PATIENTS MET THE INCLUSION CRITERIA. THE POOLED WEIGHTED MEAN DIFFERENCES WERE -23.72 MG/DL (95% CI -37.78 TO -9.65; P = 0.001; I(2) = 82%) FOR FASTING BLOOD GLUCOSE AND -0.47% (95% CI -0.87 TO -0.07; P = 0.02; I(2) = 82%) FOR HEMOGLOBIN A1C. THE WEIGHTED MEAN DIFFERENCES WERE -17.38 MG/DL (95% CI -27.88 TO -6.89; P = 0.001; I(2) = 0%) FOR POSTPRANDIAL BLOOD GLUCOSE, -18.50 MG/DL (95% CI -29.88 TO -7.11; P = 0.001; I(2) = 75%) FOR TOTAL CHOLESTEROL, 4.30 MG/DL (95% CI 3.25 TO 5.36; P < 0.00001; I(2) = 10%) FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, -12.95 MG/DL (95% CI -18.84 TO -7.06; P < 0.0001; I(2) = 37%) FOR LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND -12.57 MG/DL (95% CI -29.91 TO 4.76; P = 0.16; I(2) = 48%) FOR TRIGLYCERIDES. CONCLUSIONS: THE AVAILABLE EVIDENCE SUGGESTS THAT YOGA BENEFITS ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS. HOWEVER, CONSIDERING THE LIMITED METHODOLOGY AND THE POTENTIAL HETEROGENEITY, FURTHER STUDIES ARE NECESSARY TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN TYPE 2 DIABETES MELLITUS PATIENTS. 2017 19 1074 59 EFFECTS OF YOGA ON PATIENTS WITH CHRONIC NONSPECIFIC NECK PAIN: A PRISMA SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: CHRONIC NONSPECIFIC NECK PAIN (CNNP) HAS A HIGH PREVALENCE AND IS MORE COMMON AMONG YOUNGER PEOPLE. CLINICAL PRACTICE SUGGESTS THAT YOGA IS EFFECTIVE IN RELIEVING CHRONIC PAIN. OBJECTIVES: THIS META-ANALYSIS AIMED TO QUANTITATIVELY SUMMARIZE THE EFFICACY OF YOGA FOR TREATING CNNP. DATA SOURCES: WE SEARCHED FOR TRIALS IN THE ELECTRONIC DATABASES FROM THEIR INCEPTION TO JANUARY 2019. ENGLISH DATABASES INCLUDING PUBMED, MEDLINE, COCHRANE LIBRARY, EMBASE, SCOPUS, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, AND IND MED; CHINESE DATABASES INCLUDING CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE (CNKI), WANFANG DATABASE, AND VIP INFORMATION. WE ALSO CONDUCTED A MANUAL SEARCH OF KEY JOURNALS AND THE REFERENCE LISTS OF ELIGIBLE PAPERS TO IDENTIFY ANY POTENTIALLY RELEVANT STUDIES WE MAY HAVE MISSED. WE PLACED NO LIMITATIONS ON LANGUAGE OR DATE OF PUBLICATION. STUDY ELIGIBILITY CRITERIA: WE INCLUDED ONLY RANDOMIZED CONTROLLED TRIALS (RCTS) AND Q-RCTS EVALUATING THE EFFECTS OF YOGA ON PATIENTS WITH CNNP. THE PRIMARY OUTCOMES FOR THIS REVIEW WERE PAIN AND DISABILITY, AND THE SECONDARY OUTCOMES WERE CERVICAL RANGE OF MOTION (CROM), QUALITY OF LIFE (QOL), AND MOOD. PARTICIPANTS AND INTERVENTIONS: TRAILS THAT EXAMINED THE CLINICAL OUTCOMES OF YOGA INTERVENTION IN ADULTS WITH CNNP COMPARED WITH THOSE OF OTHER THERAPIES EXCEPT YOGA (E.G., EXERCISE, PILATES, USUAL CARE, ET AL) WERE INCLUDED. STUDY APPRAISAL AND SYNTHESIS METHODS: COCHRANE RISK-OF-BIAS CRITERIA WERE USED TO ASSESS THE METHODOLOGICAL QUALITY, AND REVMAN 5.3 SOFTWARE WAS USED TO CONDUCT THE META-ANALYSIS. RESULTS: A TOTAL OF 10 TRIALS (N = 686) COMPARING YOGA AND INTERVENTIONS OTHER THAN YOGA WERE INCLUDED IN THE META-ANALYSIS. THE RESULTS SHOW THAT YOGA HAD A POSITIVE EFFECTS ON NECK PAIN INTENSITY (TOTAL EFFECT: SMD = -1.13, 95% CI [-1.60, -0.66], Z = 4.75, P < .00001), NECK PAIN-RELATED FUNCTIONAL DISABILITY (TOTAL EFFECT: SMD = -0.92, 95% CI [-1.38, -0.47], Z = 3.95, P < .0001), CROM (TOTAL EFFECT: SMD = 1.22, 95% CI [0.87, 1.57], Z = 6.83, P < .00001), QOL (TOTAL EFFECT: MD = 3.46, 95% CI [0.75, 6.16], Z = 2.51, P = .01), AND MOOD (TOTAL EFFECT: SMD = -0.61, 95% CI [-0.95, -0.27], Z = 3.53, P = .0004). CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: IT WAS DIFFICULT TO MAKE A COMPREHENSIVE SUMMARY OF ALL THE EVIDENCE DUE TO THE DIFFERENT SESSION AND DURATION OF THE YOGA INTERVENTIONS, AND THE DIFFERENT OUTCOME MEASUREMENT TOOLS IN THE STUDY, WE DRAW A VERY CAUTIOUS CONCLUSION THAT YOGA CAN RELIEVE NECK PAIN INTENSITY, IMPROVE PAIN-RELATED FUNCTION DISABILITY, INCREASE CROM, IMPROVE QOL, AND BOOST MOOD. THIS SUGGESTS THAT YOGA MIGHT BE AN IMPORTANT ALTERNATIVE IN THE TREATMENT OF CNNP. SYSTEMATIC REVIEW REGISTRATION NUMBER: DETAILS OF THE PROTOCOL FOR THIS SYSTEMATIC REVIEW AND META-ANALYSIS WERE REGISTERED ON PROSPERO AND CAN BE ACCESSED AT WWW.CRD.YORK.AC.UK/PROSPERO/DISPLAY_RECORD.ASP?ID=CRD42018108992. 2019 20 2518 63 YOGA COMPARED TO NON-EXERCISE OR PHYSICAL THERAPY EXERCISE ON PAIN, DISABILITY, AND QUALITY OF LIFE FOR PATIENTS WITH CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: CHRONIC LOW BACK PAIN (CLBP) IS A COMMON AND OFTEN DISABLING MUSCULOSKELETAL CONDITION. YOGA HAS BEEN PROVEN TO BE AN EFFECTIVE THERAPY FOR CHRONIC LOW BACK PAIN. HOWEVER, THERE ARE STILL CONTROVERSIES ABOUT THE EFFECTS OF YOGA AT DIFFERENT FOLLOW-UP PERIODS AND COMPARED WITH OTHER PHYSICAL THERAPY EXERCISES. OBJECTIVE: TO CRITICALLY COMPARE THE EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, QUALITY OF LIFE WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION), PHYSICAL THERAPY EXERCISE. METHODS: THIS STUDY WAS REGISTERED IN PROSPERO, AND THE REGISTRATION NUMBER WAS CRD42020159865. RANDOMIZED CONTROLLED TRIALS (RCTS) OF ONLINE DATABASES INCLUDED PUBMED, WEB OF SCIENCE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, EMBASE WHICH EVALUATED EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, AND QUALITY OF LIFE WERE SEARCHED FROM INCEPTION TIME TO NOVEMBER 1, 2019. STUDIES WERE ELIGIBLE IF THEY ASSESSED AT LEAST ONE IMPORTANT OUTCOME, NAMELY PAIN, BACK-SPECIFIC DISABILITY, QUALITY OF LIFE. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE METHODOLOGICAL QUALITY OF INCLUDED RANDOMIZED CONTROLLED TRIALS. THE CONTINUOUS OUTCOMES WERE ANALYZED BY CALCULATING THE MEAN DIFFERENCE (MD) OR STANDARDIZED MEAN DIFFERENCE (SMD) WITH 95% CONFIDENCE INTERVALS (CI) ACCORDING TO WHETHER COMBINING OUTCOMES MEASURED ON DIFFERENT SCALES OR NOT. RESULTS: A TOTAL OF 18 RANDOMIZED CONTROLLED TRIALS WERE INCLUDED IN THIS META-ANALYSIS. YOGA COULD SIGNIFICANTLY REDUCE PAIN AT 4 TO 8 WEEKS (MD = -0.83, 95% CI = -1.19 TO -0.48, P<0.00001, I2 = 0%), 3 MONTHS (MD = -0.43, 95% CI = -0.64 TO -0.23, P<0.0001, I2 = 0%), 6 TO 7 MONTHS (MD = -0.56, 95% CI = -1.02 TO -0.11, P = 0.02, I2 = 50%), AND WAS NOT SIGNIFICANT IN 12 MONTHS (MD = -0.52, 95% CI = -1.64 TO 0.59, P = 0.36, I2 = 87%) COMPARED WITH NON-EXERCISE. YOGA WAS BETTER THAN NON-EXERCISE ON DISABILITY AT 4 TO 8 WEEKS (SMD = -0.30, 95% CI = -0.51 TO -0.10, P = 0.003, I2 = 0%), 3 MONTHS (SMD = -0.31, 95% CI = -0.45 TO -0.18, P<0.00001, I2 = 30%), 6 MONTHS (SMD = -0.38, 95% CI = -0.53 TO -0.23, P<0.00001, I2 = 0%), 12 MONTHS (SMD = -0.33, 95% CI = -0.54 TO -0.12, P = 0.002, I2 = 9%). THERE WAS NO SIGNIFICANT DIFFERENCE ON PAIN, DISABILITY COMPARED WITH PHYSICAL THERAPY EXERCISE GROUP. FURTHERMORE, IT SUGGESTED THAT THERE WAS A NON-SIGNIFICANT DIFFERENCE ON PHYSICAL AND MENTAL QUALITY OF LIFE BETWEEN YOGA AND ANY OTHER INTERVENTIONS. CONCLUSION: THIS META-ANALYSIS PROVIDED EVIDENCE FROM VERY LOW TO MODERATE INVESTIGATING THE EFFECTIVENESS OF YOGA FOR CHRONIC LOW BACK PAIN PATIENTS AT DIFFERENT TIME POINTS. YOGA MIGHT DECREASE PAIN FROM SHORT TERM TO INTERMEDIATE TERM AND IMPROVE FUNCTIONAL DISABILITY STATUS FROM SHORT TERM TO LONG TERM COMPARED WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION). YOGA HAD THE SAME EFFECT ON PAIN AND DISABILITY AS ANY OTHER EXERCISE OR PHYSICAL THERAPY. YOGA MIGHT NOT IMPROVE THE PHYSICAL AND MENTAL QUALITY OF LIFE BASED ON THE RESULT OF A MERGING. 2020